Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
O&P of Pinehurst — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cape Fear Valley Health System ( Site 0136) — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Scheduled or As Needed Pain Regimen?
Pain, Postoperative
Phase 4
Interventional 90 participants sought
Cape Fear Valley Medical Center — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Cape Fear Valley Health System
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Daiichi Sankyo
Confirmatory Clinical Study in Active Ulcerative Colitis
Colitis, Ulcerative
Phase 2
Interventional 204 participants sought
Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi)
· Sponsor: MRM Health NV
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Medtronic
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 130 participants sought
FirstHealth of the Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Akero Therapeutics, Inc
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: AstraZeneca
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Exact Sciences Corporation
Comparative Performance of a Vaginal Yeast Test
Vulvovaginal Candidiasis
N/A
Observational 1,200 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Uniformed Services University of the Health Sciences
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: pH-D Feminine Health LLC
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Cervical Cancer
N/A
Interventional 840 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: GOG Foundation
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Integrated Cancer Repository for Cancer Research
Multiple conditions
N/A
Observational 999,999 participants sought
Cape Fear Valley Health System — Fayetteville, North Carolina (6.0 mi)
· Sponsor: University of Nebraska
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Coastal Research Institute - Fayetteville — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Eli Lilly and Company
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Posttraumatic Headache, Mild Traumatic Brain Injury
Phase 2
Interventional 404 participants sought
Womack Army Medical Center - Fort Liberty — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
Chronic Ankle Instability
N/A
Interventional 180 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Womack Army Medical Center
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Pinehurst, North Carolina (28.8 mi)
· Sponsor: DalCor Pharmaceuticals
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Endometrial Adenocarcinoma
Phase 2
Interventional 350 participants sought
FirstHealth of the Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Acrivon Therapeutics
Empowering Young Parents: Building Healthy Relationships Study
Gender-based Violence, Intimate Partner Violence
N/A
Interventional 600 participants sought
Empowering Connections, Partnership for Children & Families — Sanford, North Carolina (29.6 mi)
· Sponsor: RTI International